14 reports

The patient model consists of men with HIV who have sex with men.

  • Healthcare
  • Pancreatic Cancer
  • Pharmaceutical
  • United States
  • GlobalData's company
  • PIPELINE BY ONCOVIR INC, H2 2017
  • Toll Like Receptor 3 (CD283 or TLR3) - Dormant Products

In May 2010, Rockefeller University registered a randomized, placebo-controlled, dose-escalating, double-blinded Phase I study to evaluate the safety and immunogenicity of Anti-DEC-## monoclonal antibody (mab) targeted HIV Gag p## vaccine (DCVax-##) with poly ICLC (Hiltonol) as adjuvant i

  • Biopharmaceutical
  • Pancreatic Cancer
  • United States
  • Product Initiative
  • Hemispherx Biopharma, Inc.

Mechanism Of Action SYNTHETIC PEPTIDE TO TARGET CXCR## AND SDF-## FOR HIV - DRUG PROFILE SYNTHETIC PEPTIDES TO ACTIVATE SDF-## ALPHA FOR CNS DISORDERS AND INFECTIOUS DISEASE - DRUG PROFILE Stromal Cell Derived Factor ## (C-X-C Motif Chemokine ## or Intercrine Reduced in Hepatomas or SDF## or Pre

  • Pancreatic Cancer
  • Pharmaceutical
  • United States
  • Product Initiative
  • Juventas Therapeutics, Inc.
  • Inflammation
  • PIPELINE BY ONCOVIR INC, H1 2017
  • Biopharmaceutical
  • Cancer
  • Pancreatic Cancer
  • Product Initiative
  • Hemispherx Biopharma, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • RECOMBINANT PROTEIN TO ANTAGONIZE CXCR4 FOR ONCOLOGY - DRUG PROFILE
  • Cancer
  • Pancreatic Cancer
  • United States
  • Product Initiative
  • BioLineRx Ltd.
  • PIPELINE BY BRISTOL-MYERS SQUIBB COMPANY, H2 2016
  • PRODUCTS UNDER INVESTIGATION BY UNIVERSITIES/INSTITUTES, H2 2016
  • Cancer
  • Pancreatic Cancer
  • Research And Development
  • Therapy
  • BioLineRx Ltd.
  • DIAGNOSTIC TEST - PANCREATIC CANCER - PRODUCT STATUS
  • DIAGNOSTIC TEST - PANCREATIC CANCER - PRODUCT DESCRIPTION

HIV/ AIDS and other life threatening diseases.

  • Clinical Trial
  • Immunochemistry Test
  • Pancreatic Cancer
  • United States
  • GlobalData's company
  • Cell Therapy
  • Pancreatic Cancer
  • United States
  • Product Initiative
  • Ohr Pharmaceutical Inc.
  • PANCREATIC CANCER - PIPELINE BY AMCURE GMBH, H2 2017
  • PANCREATIC CANCER - PIPELINE BY AMBRX INC, H2 2017

It develops gene-based drugs that cure liver cancer, HIV, AIDS, Parkinson' s disease, and diabetes.

  • Pancreatic Cancer
  • Pharmaceutical
  • North America
  • United States
  • Product Initiative
  • RECOMBINANT PROTEIN TO ANTAGONIZE CXCR4 FOR ONCOLOGY - DRUG PROFILE
  • PANCREATIC CANCER - PIPELINE BY AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC, H1 2017
  • Cancer
  • Pancreatic Cancer
  • North America
  • United States
  • Product Initiative
  • 5. All the trials included are unique trials.

HIV Protease Inhibitor Nelfinavir in Patients with Locally Advanced Pancreatic Cancer Combination Chemotherapy with or without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients with Locally Advanced Pancreatic Cancer GDCT## NCT01959

  • Cancer
  • Pancreatic Cancer
  • Pharmaceutical
  • United States
  • World
  • METASTATIC PANCREATIC CANCER - PIPELINE BY BRISTOL-MYERS SQUIBB COMPANY, H1 2016
  • Chemotherapy
  • Pancreatic Cancer
  • United States
  • Company
  • Product Initiative

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Lung Cancer
  • Pancreatic Cancer
  • Pharmaceutical
  • United States
  • Product Initiative
  • METASTATIC PANCREATIC CANCER - PIPELINE BY BRISTOL-MYERS SQUIBB COMPANY, H2 2016
  • METASTATIC PANCREATIC CANCER - PIPELINE BY GILEAD SCIENCES, INC., H2 2016
  • Chemotherapy
  • Pancreatic Cancer
  • United States
  • Company
  • Product Initiative